Product search
Sort by
Search results
BIOPHEN DTI (Direct Thrombin Inhibitors)
Assay proposed for the measurement of anti-IIa activity in research applications.
BIOPHEN Heparin LRT 7.5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra ® , Orgaran ® , rivaroxaban (Xarelto ® ), apixaban (Eliquis ® ) and edoxaban (Lixiana ® ) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 3 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra ® , Orgaran ® , rivaroxaban (Xarelto ® ), apixaban (Eliquis ® ) and edoxaban (Lixiana ® ) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN Heparin LRT 5 (Liquid Reagent Technology)
Measuring the concentration of UFH, LMWH, Arixtra ® , Orgaran ® , rivaroxaban (Xarelto ® ), apixaban (Eliquis ® ) and edoxaban (Lixiana ® ) in patients’ plasma for monitoring the therapy and adjusting drug dosage.
BIOPHEN DiXaI (Direct Xa Inhibitors)
Measurement of rivaroxaban and other factor Xa inhibitors in citrated plasma or other biological fluids. Note: BIOPHEN Heparin LRT and BIOPHEN Heparin (3 or 6) can also be used for testing direct factor Xa inhibitors (DiXaIs), such as rivaroxaban, apixaban or edoxaban. Adjusted protocols are available on demand.